These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 15675723)
1. New developments in diagnosis and treatment of Parkinson's disease--from basic science to clinical applications. Storch A; Hofer A; Krüger R; Schulz JB; Winkler J; Gerlach M J Neurol; 2004 Sep; 251 Suppl 6():VI/33-8. PubMed ID: 15675723 [TBL] [Abstract][Full Text] [Related]
2. Neuroreplacement, growth factor, and small molecule neurotrophic approaches for treating Parkinson's disease. O'Neill MJ; Messenger MJ; Lakics V; Murray TK; Karran EH; Szekeres PG; Nisenbaum ES; Merchant KM Int Rev Neurobiol; 2007; 77():179-217. PubMed ID: 17178475 [No Abstract] [Full Text] [Related]
3. Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy. Stoof JC; Winogrodzka A; van Muiswinkel FL; Wolters EC; Voorn P; Groenewegen HJ; Booij J; Drukarch B Eur J Pharmacol; 1999 Jun; 375(1-3):75-86. PubMed ID: 10443566 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotection for Parkinson's disease using viral vector-mediated delivery of GDNF. McBride JL; Kordower JH Prog Brain Res; 2002; 138():421-32. PubMed ID: 12432782 [No Abstract] [Full Text] [Related]
5. Parkinson's disease and related disorders--XVIII WFN World Congress. Grosset D IDrugs; 2010 Feb; 13(2):82-4. PubMed ID: 20127558 [TBL] [Abstract][Full Text] [Related]
6. Future and current surgical therapies in Parkinson's disease. Betchen SA; Kaplitt M Curr Opin Neurol; 2003 Aug; 16(4):487-93. PubMed ID: 12869808 [TBL] [Abstract][Full Text] [Related]
7. The conundrum of neuroprotection in Parkinson's disease. Antonini A Lancet Neurol; 2011 May; 10(5):396-7. PubMed ID: 21482192 [No Abstract] [Full Text] [Related]
8. Neuroprotection for Parkinson's disease: prospects and promises. Olanow CW; Schapira AH; Agid Y Ann Neurol; 2003; 53 Suppl 3():S1-2. PubMed ID: 12666093 [No Abstract] [Full Text] [Related]
9. [Parkinson's disease: dealing with all dimensions of the disease]. Fénelon G Rev Prat; 2005 Apr; 55(7):714-6. PubMed ID: 15966413 [No Abstract] [Full Text] [Related]
10. Therapeutic innovation in Parkinson's disease: a 2020 update on disease-modifying approaches. Colombo D; Pnevmatikou P; Melloni E; Keywood C Expert Rev Neurother; 2020 Oct; 20(10):1047-1064. PubMed ID: 32758042 [TBL] [Abstract][Full Text] [Related]
11. Cerebral Dopamine Neurotrophic Factor: A Potential Therapeutic Agent for Parkinson's Disease. Tang T; Li Y; Jiao Q; Du X; Jiang H Neurosci Bull; 2017 Oct; 33(5):568-575. PubMed ID: 28337696 [TBL] [Abstract][Full Text] [Related]
13. Clinical approaches to the development of a neuroprotective therapy for PD. Olanow CW; Kieburtz K; Katz R Exp Neurol; 2017 Dec; 298(Pt B):246-251. PubMed ID: 28622912 [TBL] [Abstract][Full Text] [Related]
14. Stem Cell Replacement Therapies in Parkinson's Disease. Zeng L; Chan LL; Lim EC; Tan EK Ann Acad Med Singap; 2019 Apr; 48(4):112-114. PubMed ID: 31131382 [No Abstract] [Full Text] [Related]